The Legacy of Parasitic Colonial Diseases: Unfinished Business in Global Health.

Elena Petrova

doi:DOI:10.35841/aapddt-9.4.205

Short Communication - Journal of Parasitic Diseases: Diagnosis and Therapy (2024) Volume 9, Issue 4

The Legacy of Parasitic Colonial Diseases: Unfinished Business in Global Health.

Badiaga S, Brouqui P. Human louse-transmitted infectious diseases. Clin Microbiol Infect. 2012;18(4):332-7.

Indexed at, Google Scholar, Cross Ref

Leung AK, Fong JH, Pinto-Rojas A. Pediculosis capitis. J Pediatr Health Care. 2005;19(6):369-73.

Google Scholar

Virrueta Herrera S, Johnson KP, Sweet AD, Ylinen E, Kunnasranta M, et al . High levels of inbreeding with spatial and host-associated structure in lice of an endangered freshwater seal. Mol Ecol. 2022;31(18):4593-606.

Indexed at, Google Scholar, Cross Ref

Feldmeier H. Pediculosis capitis: new insights into epidemiology, diagnosis and treatment. Eur J Clin Microbiol. 2012;31:2105-10.

Indexed at, Google Scholar, Cross Ref

Burgess IF, Lee PN, Brown CM. Randomised, controlled, parallel group clinical trials to evaluate the efficacy of isopropyl myristate/cyclomethicone solution against head lice. Pharma J ;280. 2008.

Indexed at, Google Scholar

Jg M. Liesenfeld O. Toxoplasmosis. The Lancet. 2004;363(9425):1965-76.

Indexed at, Google Scholar, Cross Ref

Fayer R, Xiao L, editors. Cryptosporidium and cryptosporidiosis. CRC Pre; 2007.

Indexed at, Google Scholar

Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int. J. Parasitol. 2000;30(12-13):1217-58.

Indexed at, Google Scholar, Cross Ref

Checkley W, White AC, Jaganath D, Arrowood MJ, Chalmers RM, et al. A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium. Lancet Infect Dis. 2015;15(1):85-94.

Indexed at, Google Scholar, Cross Ref

Lindsay DS, Dubey JP. Toxoplasma gondii: the changing paradigm of congenital toxoplasmosis. Parasitol. 2011;138(14):1829-31.

Indexed at, Google Scholar, Cross Ref

Visit for more related articles at Journal of Parasitic Diseases: Diagnosis and Therapy

Elena Petrova^*

Center for Molecular Parasitology, Moscow State University, Russia

Colonial history leaves behind complex legacies—many visible, some insidious. Among the most enduring and troubling are parasitic diseases, which remain a health burden disproportionately affecting populations in formerly colonized regions. These afflictions, such as malaria, schistosomiasis, and leishmaniasis, were not merely medical challenges but became instruments of control, symbols of exploitation, and reflections of inequity. Today, their persistence is a stark reminder of unfinished business in global health.

A Colonial Tool of Control

During colonial expansion, European powers encountered unfamiliar diseases, often viewing them as exotic threats or hindrances to their agendas. Malaria, for instance, was both a barrier to conquest and a justification for dominating tropical regions under the guise of "civilizing missions." British, French, and Portuguese empires developed sophisticated control measures—not primarily to protect local populations but to safeguard their colonial officials, troops, and economic interests.

Colonial infrastructure decisions were deeply linked to disease dynamics. Investments were made in controlling diseases where economic assets—like plantations or mines—were at risk, not where local health needs were greatest. These selective interventions deepened disparities that persist today.

Parasites as Symbols of Stigma

Beyond the biological impact, parasitic diseases carried stigmatizing narratives. European colonizers often depicted the presence of diseases like leprosy or "tropical fever" as evidence of local backwardness. This framing justified colonial interventions and fostered a long-lasting stereotype: that these regions were inherently diseased, needing external governance.

Such attitudes influenced medical research and funding priorities. Post-independence, many countries found themselves without the resources to tackle these diseases effectively, a gap exacerbated by the extraction of wealth during colonial rule.

The Postcolonial Burden

Decolonization brought political independence but limited health sovereignty. Countries faced immense challenges with weak healthcare infrastructures ill-equipped to address endemic diseases. International aid programs often focused on diseases of global concern rather than local priorities, sometimes neglecting the control of endemic parasites.

Today, diseases like schistosomiasis (caused by parasitic worms) or leishmaniasis (a neglected tropical disease) remain prevalent in areas with limited access to clean water, sanitation, and healthcare—conditions worsened by colonial legacies of exploitation and environmental degradation.

Reversing the Tide: The Path Forward

Tackling these diseases requires more than biomedical solutions. It demands addressing structural inequalities and investing in local health infrastructure and education. International efforts must center on the needs of affected communities rather than donor-driven agendas. Initiatives like the WHO's Neglected Tropical Diseases program offer hope, but progress remains slow without sustained global commitment.

Conclusion

Parasitic diseases are not merely biological afflictions; they are historical and political phenomena deeply intertwined with colonial pasts. Their continued prevalence is a call to address historical wrongs through equity-focused health policies. Only by confronting this legacy can we hope to turn the page on an era where disease control served power, not people.